| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash used in financing activities | -189,150 | -142,737 |
| Net effect of exchange rate changes on cash and cash equivalents | 1,474 | 1,794 |
| Net (decrease) increase in cash and cash equivalents | -2,527 | -24,920 |
| Cash and cash equivalents at beginning of period | 127,665 | - |
| Cash and cash equivalents at end of period | 125,138 | - |
CORCEPT THERAPEUTICS INC (CORT)
CORCEPT THERAPEUTICS INC (CORT)